BELEODAQ Trademark

Trademark Overview

On Tuesday, December 10, 2013, a trademark application was filed for BELEODAQ with the United States Patent and Trademark Office. The USPTO has given the BELEODAQ trademark a serial number of 86140026. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, February 27, 2020. This trademark is owned by SPECTRUM PHARMACEUTICALS, INC.. The BELEODAQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, those for the treatment, prevention, and diagnosis of bacterial infections, fungal infections and inflammatory, nephrological, neurological, oncological, and urological conditions and diseases
beleodaq

General Information

Serial Number86140026
Word MarkBELEODAQ
Filing DateTuesday, December 10, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, February 27, 2020
Registration Number4626277
Registration DateTuesday, October 21, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, those for the treatment, prevention, and diagnosis of bacterial infections, fungal infections and inflammatory, nephrological, neurological, oncological, and urological conditions and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 24, 2013
Primary Code005
First Use Anywhere DateSunday, July 20, 2014
First Use In Commerce DateSunday, July 20, 2014

Trademark Owner History

Party NameACROTECH BIOPHARMA INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressEAST WINDSOR, NJ 08520
Party NameACROTECH BIOPHARMA LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressEAST WINDSOR, NJ 08520
Party NameSPECTRUM PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92618
Party NameSPECTRUM PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92618
Party NameSPECTRUM PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92618

Trademark Events

Event DateEvent Description
Wednesday, March 19, 2014ASSIGNED TO EXAMINER
Friday, December 13, 2013NEW APPLICATION ENTERED
Tuesday, December 24, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 14, 2014ASSIGNED TO LIE
Thursday, March 20, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 20, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, March 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 20, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, March 20, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, April 14, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 20, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 20, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 15, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 11, 2014TEAS STATEMENT OF USE RECEIVED
Monday, August 11, 2014USE AMENDMENT FILED
Thursday, August 28, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 10, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, September 12, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 13, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 21, 2014REGISTERED-PRINCIPAL REGISTER
Monday, October 21, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 5, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 2, 2020TEAS SECTION 8 & 15 RECEIVED
Thursday, February 27, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 27, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 27, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 14, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 24, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, October 21, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

beleodaq infections neurological nephrological inflammatory oncological urological diseases conditions fungal pharmaceutical